Nucleic-acid- and cell-based therapeutics - Pharmaceutical Biotechnology: Concepts and Aapplications - page 463

Blankenstein, T. (Ed.) 1999. Gene Therapy, Principles and Applications . Birkhauser Verlag.
Lowrie, D. 1999. DNA Vaccines . Humana Press.
Phillips, M. 2000. Antisense Technology . Methods in Enzymology, volume 313. Academic Press.
Crooke, S. (Ed.) 2001. Antisense Drug Technology . Marcel Dekker.
Stein, C. and Krieg, A.1998. Applied Antisense Oligonucleotide Technology . Wiley.
Articles
Gene therapy
Buchschacher, G. and Wong-Staal, F. 2001. Approaches to gene therapy for human immunodefi ciency virus
infection. Human Gene Therapy 12 (9), 1013-1019.
Davies, J.C., Geddes, D.M., and Alton, E.W. 2001. Gene therapy for cystic fi brosis. Journal of Gene Medicine
3 (5), 409-417.
Demeterco, C. and Levine, F. 2001. Gene therapy for diabetes. Frontiers in Bioscience 6 , D175-D191.
Edelstein, M.L., Abedi, M.R., Wixon, J., and Edelstein, R.M. 2004. Gene therapy clinical trials worldwide
1989-2004 - an overview. Journal of Gene Medicine 6 (6), 597-602.
Eliyahu, H., Barenholz, Y., and Domb, A.J. 2005. Polymers for DNA delivery. Molecules 10 (1), 34 - 64.
Ferguson, C., Larochelle, A., and Dunbar, C.E. 2005. Hematopoietic stem cell gene therapy: dead or alive?
Trends in Biotechnology 23 (12), 589-597.
Ferreira, G.N., Monteiro, G.A., Prazeres, D.M., and Cabral, J.M. 2000. Downstream processing of plasmid DNA
for gene therapy and DNA vaccine applications. Trends in Biotechnology 18 (9), 380-388.
Furlan, R., Butti, E., Pluchino, S., and Martino, G. 2004. Gene therapy for autoimmune diseases. Current Opin-
ion in Molecular Therapeutics 6 (5), 525-536.
Gardlik, R., Palffy, R., Hodosy, J., Lukacs, J., Turna, J., and Celec, P. 2005. Vectors and delivery systems in gene
therapy. Medical Science Monitor 11 (4), RA110-RA121.
Lewin, A. and Hauswirth, W. 2001. Ribozyme gene therapy: applications for molecular medicine. Tren ds in
Molecular Medicine 7 (5), 221-228.
Mhashilkar A, Chada S, Roth JA, and Ramesh R. 2001. Gene therapy - therapeutic approaches and implications.
Biotechnology Advances 19 (4), 279-297.
Ohlfest, J.R., Freese, A.B., and Largaespada, D.A. 2005. Nonviral vectors for cancer gene therapy: prospects for
integrating vectors and combination therapies. Current Gene Therapy 5 (6), 629-641.
Palmer, D.H., Young, L.S., and Mautner, V. 2006. Cancer gene therapy: clinical trials. Tren ds in Biotech nology
24 (2), 76-82.
Phillips, A. 2001. The challenge of gene therapy and DNA delivery. Journal of Pharmacy and pharmacology .
53 (9), 1169-1174.
Pfeifer, A. and Verma, I. 2001. Gene therapy: promises and problems. Annual review of genomics and Human
Genetics 2 , 177-211.
Robertson, J. and Griffi ths, E. 2001. Assuring the quality, safety and effi cacy of DNA vaccines. Molecular
Biotechnology 17 (2), 143 -149.
Schatzlein, A. 2001. Non-viral vectors in cancer gene therapy: principles and progress. Anti-Cancer Drugs 12 (4),
275-304.
Smith, H. and Klinman, D. 2001. The regulation of DNA vaccines. Current Opinion in Biotechnology 12 (3),
299-303.
Verma, I. and Weitzman, M. 2005. Gene therapy: twenty fi rst century medicine. Annual Review of Biochemistry
74 , 711-738.
Wu, N. and Ataai, M. 2000. Production of viral vectors for gene therapy applications. Current Opinion in
Biotechnology 11 (2), 205-208.